• Users Online: 387
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2018  |  Volume : 35  |  Issue : 1  |  Page : 49-53

Distribution of the chemokine receptor-5 gene in Egyptian breast cancer patients

Medical Biochemistry and Head of Molecular Biology Unit, Faculty of Medicine, Benha University, Benha, Egypt

Correspondence Address:
Hebat Allah E.M Ahmed
El-Shorouq City, Cairo, 11837
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/bmfj.bmfj_191_17

Rights and Permissions

Background Chemokine receptor type-5 (CCR5)-Δ32, a 32-base pair deletion of the C–C CCR5 gene, is associated with slowed human immunodeficiency virus disease progression in heterozygotes and protection against infection in homozygotes between carriers and noncarriers of each genetic variant. Aim The present study aimed to investigate the frequency of the CCR5-Δ32 mutation in Egyptian breast cancer (BC) patients. Materials and methods We determined the genotypic frequency of wild and mutant variants of CCR5 in 40 BC patients and 20 healthy individuals using restriction fragment length polymorphism and reverse hybridization. Results We found the absence of heterozygous and homozygous mutant gene variants in both BC patients and controls. Conclusion No significant difference in the frequency of CCR5 genotypes and alleles between patients and controls and no association between that gene and BC.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded45    
    Comments [Add]    

Recommend this journal